Democratic governors defend sanctuary policies against Republican criticism over public safety concerns and violent crimes linked to undocumented immigrants.
BioNTech to acquire German rival CureVac in $1.25B all-stock deal, bolstering its mRNA capabilities.
Democratic governors defend sanctuary policies against Republican criticism over public safety concerns and violent crimes linked to undocumented immigrants.
BioNTech to acquire German rival CureVac in $1.25B all-stock deal, bolstering its mRNA capabilities.